CN112142663A
|
|
Synthesis method of (S) -1-phenyl-1, 2,3, 4-tetrahydroisoquinoline
|
CN112250533A
|
|
Synthesis method of (S) -1- (3-ethoxy-4-methoxyphenyl) -2- (methylsulfonyl) ethylamine
|
CN112125837A
|
|
Preparation method of avibactam intermediate
|
CN112174909A
|
|
Preparation method of aprepitant intermediate
|
CN111592499A
|
|
Preparation method of Favipiravir
|
CN111606782A
|
|
Synthesis method of (S) -1- (2, 6-dichloro-3-fluorophenyl) -ethanol
|
CN111574367A
|
|
Synthesis method of (S) -methyl-2- [3- (3-bromophenyl) -3-hydroxypropyl ] methyl benzoate
|
CN111574323A
|
|
Preparation method of R-1- (naphthalene-1-yl) ethanol
|
CN111518046A
|
|
Ezetimibe intermediate and preparation method of ezetimibe
|
CN111518000A
|
|
Preparation method of (R) -1- (3-ethoxy-4-methoxyphenyl) -2- (methylsulfonyl) ethanol)
|
CN111454258A
|
|
Preparation method of solifenacin intermediate
|
CN111474262A
|
|
Method for detecting crizotinib intermediate
|
CN111474260A
|
|
Detection method of montelukast sodium intermediate
|
CN111458431A
|
|
Method for detecting isomer of orlistat intermediate
|
CN110963928A
|
|
Preparation method of aprepitant intermediate impurity
|
CN110683986A
|
|
Synthesis method of (S) 1-phenyl-1, 2,3, 4-tetrahydroisoquinoline
|
CN109053425A
|
|
A kind of high-purity 3-(4- chlorobenzene) glutaric acid purification preparation method
|
CN107677753A
|
|
A kind of detection method of ezetimibe intermediate
|
CN107991410A
|
|
A kind of detection method of ezetimibe intermediate
|
CN107991406A
|
|
A kind of detection method of aprepitant intermediate
|